The DUR Board provides evaluation of criteria for drug coverage within Texas Medicaid. These criteria are used in retrospective and prospective drug utilization review, and are based on the compendia and peer reviewed medical literature. Criteria and standards are periodically revised to ensure that they reflect prescribing recommendations of the current compendia and literature.

  1. _Acetylcholinesterase Inhibitors (PDF)
  2. _Aerosolized Agents - metered-dose inhalers: anticholinergic drugs (PDF)
  3. Aerosolized Agents - metered-dose inhalers: inhaled anti-inflammatory drugs (corticosteroids)
  4. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (long-acting)
  5. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (short-acting)
  6. _Angiotensin-Converting Enzyme Inhibitors (PDF)
  7. _Angiotensin II Receptor Antagonists (PDF)
  8. Antidepressant Drugs
  9. Antidiabetic Agents (oral)
  10. Aprepitant
  11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
  12. _Atypical Antipsychotics (long-acting injectable) (PDF)
  13. _Atypical Antipsychotics (oral) (PDF)
  14. _Benzodiazepines (oral, rectal) (PDF)
  15. _Complement Inhibitor and Enzyme/Protein Replacement Therapy (PDF)
  16. _Cyclooxygenase-2 Inhibitors (PDF)
  17. _Direct Oral Anticoagulants (PDF)
  18. Exenatide
  19. _Exogenous Insulin Products (PDF)
  20. _Fentanyl (PDF)
  21. _Fluoroquinolones (oral) (PDF)
  22. _Gabapentin (PDF)
  23. _Histamine H2 - Receptor Antagonists (PDF)
  24. _Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors (PDF)
  25. _Hydrocodone Bitartrate/Hydrocodone Polistirex (PDF)
  26. _Immune Globulins (PDF)
  27. _Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi) (PDF)
  28. _Ketorolac (oral) (PDF)
  29. _Leukotriene Receptor Antagonists (PDF)
  30. _Low-dose Quetiapine (PDF)
  31. _Low Molecular - Weight Heparins (PDF)
  32. _Memantine (PDF)
  33. _Mecasermin (PDF)
  34. _Nebulized Bronchodilators (PDF)
  35. _Nitazoxanide (PDF)
  36. _Non-sedating Antihistamines (PDF)
  37. _Non-steroidal anti-inflammatory drugs (PDF)
  38. Pramlintide
  39. _Promethazine Use In Children Less Than 2 Years of Age (PDF)
  40. _Proton Pump Inhibitors (PDF)
  41. _Rifaximin (Xifaxan)
  42. _Sedative/Hypnotics (PDF)
  43. Serotonin 5-HT3 Receptor Antagonists (oral)
  44. _Serotonin 5-HT1B/1D Receptor Agonists (PDF)
  45. _Skeletal Muscle Relaxants (PDF)
  46. _Topical Calcineurin Inhibitors - Pimecrolimus (Elidel) and Tacrolimus (Protopic) (PDF)
  47. _Tramadol (PDF)